by shenal.tissera | Nov 9, 2025
Palantir reported yet another quarter of record-breaking revenue on Monday as the company continues to expand their customer base commercially and cash in on the enthusiasm for artificial intelligence. The Denver-based software company posted $1.18 billion in revenue...
by Genna Contino | Dec 5, 2024
As pharmaceutical giant Eli Lilly evolves its popular obesity and diabetes drug, the company has discovered positive side effects that could develop into spin-off medications. Users of GLP-1 drugs, which regulate blood sugar, appetite and digestion, have reported...
by Jiana Smith | Sep 23, 2024
Off-price retailers may prove to be “recession-proof” yet again. Consumers trading down amid economic concerns have given a boost to off-price retailers. The stocks have been performing well against the index for the past three months, and the outlook for continued...
by Arvelisse Bonilla Ramos | Oct 10, 2023
The shares of ELF, Coty, and Inter Parfums continue to swiftly show gains across the market, while health and personal care lead latest retail numbers. Beauty stocks of well positioned brands continue to soar, as they prove to appeal to consumers who continue spending...
by Elizabeth Napolitano | Sep 18, 2022
U.S. stocks inched higher Thursday as investors shrugged off hawkish comments from U.S. Federal Reserve and European Central Bank officials. The S&P 500 rose about 0.7% to 4006.81 at the closing bell, while the Dow industrials added 0.6% to 31774.52. The largely...
